PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS

Pulmonary Thromboembolism

Jul 18, 2016 by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS Comments Off on Pulmonary Thromboembolism

Chapter 166 Pulmonary Thromboembolism Susan G. Hackner,     Stamford, Connecticut Pulmonary thromboembolism (PTE) occurs when thrombi that develop in the venous circulation dislodge and become trapped in the pulmonary vasculature. If the…

read more

Eosinophilic Pulmonary Diseases

Jul 18, 2016 by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS Comments Off on Eosinophilic Pulmonary Diseases

Chapter 163 Eosinophilic Pulmonary Diseases Cécile Clercx,     Liège, Belgium Dominique Peeters,     Liège, Belgium Definition and Causes Eosinophilic bronchopneumopathy (EBP) is a disease characterized by eosinophilic infiltration of the lung and bronchial mucosa….

read more

Portosystemic Shunts

Jul 18, 2016 by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS Comments Off on Portosystemic Shunts

Chapter 145 Portosystemic Shunts Karen M. Tobias,     Knoxville, Tennessee Portosystemic shunts (PSS) are vascular anomalies that divert blood from the abdominal to the systemic venous circulation while bypassing the hepatic sinusoids….

read more

Chronic Hepatitis Therapy

Jul 18, 2016 by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS Comments Off on Chronic Hepatitis Therapy

Chapter 142 Chronic Hepatitis Therapy Penny J. Watson,     Cambridge, Cambridgeshire, Great Britain Canine chronic hepatitis (CH) is defined by the World Small Animal Veterinary Association (WSAVA) Liver Standardization Group histologically as…

read more

Neospora caninum

Jul 18, 2016 by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS Comments Off on Neospora caninum

Chapter 275 Neospora caninum Jeanne E. Ficociello,     South Weymouth, Massachusetts Neospora caninum is a protozoal agent in the phylum Apicomplexa. The domestic dog and coyotes are definitive hosts, and herbivores, including…

read more
Get Clinical Tree app for offline access